GSK Investigational Site
Weiden, Bavaria 92637
0 studies enrolling now · 3 studies all time
What they study most
Crohn's Disease, Neoplasms, Breast, Neoplasms, Prostate
Studies at this site
- An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease — Stopped early
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
- Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed